| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;50:1085.)
© 2007 American Heart Association, Inc.
Original Articles |
From the Division of Nephrology, Department of Medicine, University of California San Francisco, 1291 Moffitt Hospital, San Francisco.
Correspondence to R. Curtis Morris, Jr, University of California San Francisco, 1291 Moffitt Hospital, Box 0126, San Francisco, CA 94143-0126. E-mail cmorris{at}gcrc.ucsf.edu
| Abstract |
|---|
|
|
|---|
mean arterial pressure:
5 mm Hg with NaCl load), but not in salt-resistant subjects (n=17), loading with NaHCO3 was also pressor. The pressor effect of NaHCO3 was half that of NaCl: mean arterial pressure (millimeters of mercury) increased significantly from 90 on low NaCl to 95 with NaHCO3 and to 101 with NaCl. The pressor effect of NaCl strongly predicted that of NaHCO3. As judged by hematocrit decrease, plasma volume expansion with NaCl was the same in salt-resistant and salt-sensitive subjects and twice that with NaHCO3, irrespective of the pressor effect. In salt-sensitive subjects, mean arterial pressure varied directly with plasma Na+ concentration attained with all Na+ loading. In salt-sensitive but not salt-resistant subjects, NaHCO3 and NaCl induced decreases in renal blood flow and increases in renal vascular resistance; changes in renal blood flow were not different with the 2 salts. Responses of renal blood flow and renal vascular resistance to NaHCO3 were strongly predicted by those to NaCl. In establishing the fact of "sodium-selective" salt sensitivity, the current observations demonstrate that the Na+ component of NaCl can have pressor and renal vasoconstrictive properties apart from its capacity to complement Cl– in plasma volume expansion.
Key Words: blood pressure physiopathology sodium chlorides bicarbonates renal circulation blacks
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Basal Diet
Throughout the study, participants ate a eucaloric basal metabolic diet providing, per 70 kg of BW per day, 30 mmol of Na+ and 45 mmol of K+. They drank water, 20 g/kg of BW per day, during Na+ restriction and 35 g/kg of BW during Na+ loading, respectively.
Intervention (Na+ Loading)
The study consisted of 3 consecutive 7-day periods. The 2 periods of oral Na+ loading were separated by a period of Na+ restriction. Na+, 250 mmol/70 kg of BW per day (but
300 mmol/d), was supplemented as NaCl during the first week and as NaHCO3 during the third week, or vice versa. All of the participants received placebo tablets during the second (low-salt) week. Participants and nurses performing BP measurements were not informed about the content of the tablets.
Assessment of Na+-Induced Pressor Effects
With an automated oscillometric device (Dinamap, Criticon Inc) programmed to obtain 5 readings over a period of 5 minutes, BP was measured daily every 4 hours (between 6 AM and 10 PM) after 10 minutes of supine rest; an average daily BP was calculated. The first standardized BP measurements were obtained within
2 hours of the subjects arrival at the General Clinical Research Center, at 2 PM. The 2 PM values of day 1 are reported as "initial" (baseline) BP in Table 1 and Figure 1. To determine the pressor effects of Na+ salts, the average mean arterial pressure (MAP) of days 5 and 6 during Na+ restriction was subtracted from the average MAP of days 5 and 6 during loading of either NaCl or NaHCO3. Salt sensitivity (SS) was defined as an NaCl-induced increase in MAP of
5 mm Hg and salt resistance (SR) as an increase of <5 mm Hg.
|
|
Metabolic Outcomes
We measured BW daily at 6 AM. Spontaneously voided urine was collected daily over 24-hour periods and analyzed for Na+, Cl–, and creatinine. During week 3 of the study, we measured weekly cumulative Na+ excretion, corrected for creatinine excretion and adjusted for 70 kg of BW. On the last day of each 7-day period, between 9 AM and noon, blood samples were obtained with participants in the supine position to determine levels of plasma renin activity (PRA), aldosterone, hematocrit, creatinine, and serum electrolytes by standard techniques.
Renal Hemodynamics
Para-aminohippurate clearance studies were performed in 31 participants (16 SS and 15 SR subjects) on the last day of each 7-day period using standard methods.
Data Analysis
We assessed the effects of Na+ loading as either NaCl or NaHCO3 on BP using repeated-measures ANOVA, followed by a Newman-Keuls test. To assess whether the order in which the supplements were administered had an effect on outcome, we included "supplement order" as a between-group factor in the comparison. To rule out NaHCO3- or NaCl-induced effects on serum K+9 or hematocrit as a major source of between-group differences in pressor effects, we repeated between-group comparisons of pressor effects using changes in, and final concentrations of, serum K+ and changes in hematocrit as covariates. We assessed the effects of NaCl or NaHCO3 on BW, hematocrit, electrolytes, and renal hemodynamics and the pressor effect in salt-sensitive subgroups using paired and unpaired t tests, respectively, for within-group and between-group comparisons. Nonparametric tests were used to assess the effect on PRA and aldosterone, as these variables were not normally distributed. Linear regression and Spearman rank correlation analyses were used to explore the relationship between variables. Data are presented as mean and 95% CI. The null hypothesis was rejected at P<0.05.
| Results |
|---|
|
|
|---|
MAP was 11±2 mm Hg), and 17 (49%; 15 males and 2 females) were SR (average NaCl-induced
MAP was –1±2 mm Hg; Figures 1 and 2
|
Demographic Characteristics
SS subjects were slightly older than SR subjects and had a significantly higher initial BP, higher serum Na+ concentration, and lower body mass index (Table 1). After adjusting for age and body mass index, the difference remained significant for diastolic BP and MAP but not for systolic BP.
Pressor Effects of NaHCO3
In SS but not in SR subjects, NaHCO3 loading, compared with Na+ restriction, induced a significant pressor effect (Figures 1 and 2
A and Table 2). However, this pressor effect was significantly less than that of NaCl. The sequence in which Na+ salts were administered did not affect their pressor effect (ANOVA, summary of effects: SS versus SR [group], P=0.004; NaCl versus low-NaCl versus NaHCO3 [intervention], P<0.0001; sequence [of Na+ salt], P=0.65; interaction of intervention by group, P<0.00001; interaction of intervention by sequence, P=0.58; and interaction of sequence by group, P=0.27).
|
In 11 of 18 of the SS subjects, the NaHCO3-induced increase in MAP was
5 mm Hg. In these 11 "sodium-selective" SS subjects (sNaS), the mean NaHCO3-induced increase in MAP was two thirds of that induced by equimolar amounts of NaCl (Figure 2B and Table 2). In 7 of 18 of the SS subjects, the NaHCO3-induced increase in MAP was <5 mm Hg. In these "classic" SS subjects (cSS), the mean NaCl-induced increase in MAP was significantly lower than that in sNaS. In fact, the pressor effect of NaHCO3 in sNaS was similar to that of NaCl in cSS (Figure 2B and Table 2). For all of the SS and SR subjects combined, changes in MAP induced by NaCl strongly predicted those induced by NaHCO3 (Figure 3A). Mean values of
MAP adjusted for changes in serum K+ or hematocrit were not different from unadjusted means.
|
Effects of NaHCO3 and NaCl on Renal Hemodynamics
In SS but not SR subjects, both NaHCO3 and NaCl induced significant decreases in renal blood flow (RBF) and increases in renal vascular resistance (RVR; Figure 4). Changes in RBF did not differ significantly between SS subgroups. However, average changes tended to be greater in (the more salt sensitive) sNaS than in cSS. As this study was designed to compare 2 groups only, SR and SS, subgroup analysis was not expected to have sufficient power to detect relevant differences. For all of the subjects combined, NaHCO3-induced changes in RBF and RVR, respectively, were strongly predicted by NaCl-induced changes (Figure 3B and 3C).
|
Metabolic Effects of NaHCO3 and NaCl
Both NaCl and NaHCO3 induced significant increases in BW (Figure 2C and 2D and Table 2). Increases were similar in SR and SS subjects, as well as in SS subgroups, and tended to be larger with NaCl than with NaHCO3. Both NaCl and NaHCO3 induced significant decreases in hematocrit values. Decreases were similar in SS and SR subjects but were significantly larger with NaCl than with NaHCO3 in both groups (Figure 2E and 2F and Table 2). Changes in BW and hematocrit were not predictive of pressor effects for either Na+ salt.
Cumulative Na+ excretion with loading of either NaCl or NaHCO3 did not differ between SS and SR subjects. For all of the subjects combined, cumulative Na+ excretion was 17% greater with NaHCO3 than with NaCl (P=0.07). With NaCl loading, cumulative Na+ excretion was (in millimoles per milligram of creatinine per 70 kg of BW) 0.63±0.11 in SS subjects (n=8) and 0.63±0.10 in SR subjects (n=8), and with NaHCO3 loading it was 0.78±0.16 (n=9) and 0.69±0.08 (n=8) in SS and SR subjects, respectively.
Changes in plasma aldosterone and PRA were similar with NaCl and NaHCO3 and were significant in both SR and SS subjects (Table 2). The NaCl-induced decrease in PRA but not in aldosterone was slightly but significantly greater in SR than in SS subjects. NaHCO3-induced changes did not differ between SS and SR subjects.
Both Na+ salts induced significant increases in serum levels of Na+ in SS and SR subjects. In both groups, the increase was slightly larger with NaCl than with NaHCO3, the difference being significant in SS subjects (Table 3). As expected, NaHCO3 loading induced a small but significant decrease in serum K+ in both SS and SR subjects (Table 3). Serum K+ levels remained within the reference range in all but 1 SR subject, who developed mild hypochloremic alkalosis with NaHCO3 loading. The NaHCO3-induced decrease was slightly but significantly larger in SS than in SR subjects. NaCl-loading induced a significant increase and NaHCO3 loading a significant decrease in serum Cl– in both SS and SR subjects (Table 3).
|
In SS but not in SR subjects, BP varied directly and highly significantly with the serum concentration of Na+ (R=0.541; P<0.0001). When sNaS only were included in the analysis, the relationship was stronger than in all of the SS subjects combined (Figure 5). For SS and SR subjects combined, the responses to NaHCO3 of serum Na+, aldosterone, and PRA but not those of hematocrit or K+ were strongly predicted by the responses to NaCl.
|
| Discussion |
|---|
|
|
|---|
5 mm Hg, despite a sustained restriction of dietary NaCl. Thus, salt sensitivity occurs not only frequently in blacks, but in many the phenomenon is sodium-selective in that Na+ loading is pressor without concomitant Cl– loading. In such sNaS subjects, the mean NaHCO3-induced increase in MAP was fully two thirds of that induced by equimolar NaCl loading. To our knowledge, these observations provide the first demonstrations both that a non-Cl– salt of Na+ can induce a pressor effect and that any salt other then NaCl can induce a pressor effect in humans. In one third of the currently studied SS subjects, selective Na+ loading induced little or no pressor effect. For such salt sensitivity that is induced only by Na+ and Cl– loading combined,6,10–12 we assign the modifier "classic" (cSS). In sNaS subjects, NaHCO3 induced a pressor effect similar to that induced by NaCl in cSS subjects. For all subjects combined, the pressor response to NaHCO3 loading varied directly and highly significantly with the pressor response to NaCl loading. The pressor effect of NaHCO3 loading amounted to half that of NaCl loading. These observations would suggest that, in many salt-sensitive blacks, a selective pressor effect of dietary Na+ is a major component of the pressor effect of dietary NaCl, and the magnitude of the selective pressor effect of Na+ a major determinant of the severity of NaCl sensitivity.
In previous studies of mainly white hypertensive subjects6,11 and of animal models of salt-sensitive hypertension13–15 in which selective dietary loading of Na+ failed to elicit a pressor effect, the failure might be inferred to reflect a failure to expand PV to some critical extent.2,3,5,7 As judged by the currently observed changes in hematocrit, it appears that both NaHCO3 and NaCl induced expansion of PV. In accord with previous observations,6 the current observations would indicate that PV expansion with NaHCO3 was about half that with NaCl, not only in SS but also in SR subjects.
NaCl-induced PV expansion is formulated to be a critical event in the pathogenesis of salt-sensitive BP by entraining a transient increase in cardiac output (CO) that elicits a pressor effect in 2 phases and ways: an immediate direct pressor effect and, several days later, an indirect, sustained pressor effect that is mediated by an increase in systemic vascular resistance occurring only in autoregulatory response to the increase in CO.2,3 However, in NaCl-loaded salt-sensitive subjects,16–19 the apparent extent of neither PV expansion16–19 nor increase in CO20 induced by NaCl has predicted the extent of salt sensitivity. In a recent study comparing normotensive salt-sensitive and salt-resistant blacks with respect to the time courses of their hemodynamic and metabolic responses to NaCl loading, we observed similar increases in Na+ balance, PV, and CO. By contrast, in the 2 groups, the divergent pressor responses induced by dietary NaCl loading were attended from their outset by divergent vascular responses, systemic vascular resistance decreasing sharply and immediately in the salt-resistant but changing little in the salt-sensitive subjects.20 In all of the subjects combined, the changes in systemic vascular resistance induced by NaCl on the second day of its loading were strongly predictive of the changes induced by NaCl on MAP on the seventh day of its loading; NaCl-induced changes in PV and CO were not predictive. These observations indicate that, in the salt-sensitive subjects studied, an impaired systemic vasodilatory response to NaCl loading, but not an abnormally increased PV or CO, is critical to the pathogenesis of salts pressor effect.
In keeping with these observations, in the current study, the extent to which loading with either NaCl or NaHCO3 induced PV expansion does not account for the extent of salts pressor effect. As judged by the decrease in hematocrit, the increase in PV induced by NaCl loading in the SS subject is indistinguishable from that induced in the SR subject. Indeed, while inducing a pressor effect only slightly less than that induced by NaCl, NaHCO3 induced in the sNaS subjects a decrease in hematocrit only one third that induced by NaCl in the SR subject. In all SS subjects combined, as well as in the sNaS and cSS subgroups, the Na+-induced mean changes in MAP adjusted for changes in hematocrit were not different from unadjusted mean changes in MAP. These observations and considerations suggest that, in most SS blacks, the pressor effect of dietary NaCl involves something more than its capacity to mediate osmotic expansion of PV, the only capacity of NaCl called for in the traditionally formulated mechanism of NaCls pressor effect.2,3,5
In the SS subjects, and particularly in the sNaS subgroup, BP varied directly and highly significantly with the serum concentration of Na+, with and without Na+ loading, but not with changes induced in BW or hematocrit. This observation suggests that, in some sult-sensitive humans, the plasma concentration of Na+ attained with Na+ loading may critically determine the extent of the pressor effect of dietary NaCl. The observation accords with observations that Qi et al21 reported in the NaCl-loaded Dahl SS/Jr rat, in which BP varied directly and highly significantly with plasma Na+ concentration, irrespective of the hydration state orally imposed. Qi et al21 proposed, as have others,4,22,23 that "directly mediated increases in plasma Na+ can increase arterial BP in rats by mechanisms that are apparently not related to fluid volume changes." An increase in plasma Na+ concentration may elicit a pressor effect by increasing cerebro-spinal fluid Na+ concentration24 and by thereby activating central sympathoexcitatory mechanisms that give rise to increased sympathetic outflow.21,25–27
In SS but not in SR subjects, NaHCO3, as well as NaCl loading, induced a clear-cut reduction in RBF and, hence, a robust increase in RVR, a phenomenon described previously only with NaCl loading in sult-sensitive humans,28,29 including normotensive blacks.19 Clearly, the Cl– component of NaCl is not required to elicit this dysfunctional renal hemodynamic response to Na+ loading. It has been proposed that a similar renal hemodynamic response is critically involved in the salt sensitivity of patients with "nonmodulating" essential hypertension.30 The extent of Na+-induced renal vasoconstrictive changes in those with salt sensitivity has been related to the extent of their pressor response.19,31
Perspectives
In establishing the fact of "sodium-selective" salt sensitivity, and its occurrence in many blacks who are salt-sensitive, the current observations extend to human relevance the consideration of ion-selective pressor phenomena, observed previously only as Cl–-sensitive hypertension in the spontaneously hypertensive rat32 and in the stroke-prone spontaneously hypertensive rat.33,34 In some instances of salt sensitivity, initiation of the pressor effect of dietary NaCl would appear to require something beyond, or other than, an abnormally enhanced renal retention of its ionic components and their complimentary osmotic capacities to expand PV,20,33,34 possibly an increase in plasma Na+ that elicits an increased central nervous system sympathetic outflow.4,21–23,25,27 Accordingly, the current observations expand the scope of possible pathogenic mechanisms of human hypertension and, hence, the scope of its potential treatment and prevention.
| Acknowledgments |
|---|
Sources of Funding
This research was supported by National Institutes of Health, National Heart, Lung, and Blood Institute grant RO1-HL64230 and gifts from the Emil Mosbacher, Jr, Foundation. Studies were carried out at the General Clinical Research Center, Moffitt/MZ Hospital, University of California San Francisco, with funds provided by the National Center for Research Resources (M0 RR-00079), US Public Health Service.
Disclosures
None.
Received April 17, 2007; first decision May 8, 2007; accepted September 13, 2007.
| References |
|---|
|
|
|---|
2. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001; 104: 545–556.[CrossRef][Medline] [Order article via Infotrieve]
3. Guyton AC. Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol. 1990; 259: R865–R877.[Medline] [Order article via Infotrieve]
4. Meneton P, Jeunemaitre X, De Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005; 85: 679–715.
5. Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol. 2006; 290: R514–R523.
6. Kurtz TW, Al-Bander HA, Morris RC Jr. "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? N Engl J Med. 1987; 317: 1043–1048.[Abstract]
7. Kotchen TA. To salt, or not to salt? Am J Physiol. 1999; 276: H1807–H1810.[Medline] [Order article via Infotrieve]
8. OShaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest. 2004; 113: 1075–1081.[CrossRef][Medline] [Order article via Infotrieve]
9. Morris RC Jr, Sebastian A, Forman A, Tanaka M, Schmidlin O. Normotensive salt-sensitivity: effects of race and dietary potassium. Hypertension. 1999; 33: 18–23.
10. Sharma AM, Schattenfroh S, Thiede H-M, Oelkers W, Distler A. Effects of sodium salts on pressor reactivity in salt-sensitive men. Hypertension. 1992; 19: 541–548.
11. Shore AC, Markandu ND, MacGregor GA. A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens. 1988; 6: 613–617.[CrossRef][Medline] [Order article via Infotrieve]
12. Luft FC, Zemel MB, Sowers JA, Fineberg NS, Weinberger MH. Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. J Hypertens. 1990; 8: 663–670.[CrossRef][Medline] [Order article via Infotrieve]
13. Kurtz TW, Morris RC Jr. Dietary chloride as a determinant of "sodium-dependent" hypertension. Science. 1983; 222: 1139–1141.
14. Whitescarver SA, Ott CE, Jackson BA, Guthrie GP Jr, Kotchen TA. Salt-sensitive hypertension: contribution of chloride. Science. 1984; 223: 1430–1432.
15. Luft FC, Steinberg H, Ganten U, Meyer D, Gless KH, Lang RE, Fineberg NS, Rascher W, Unger T, Ganten D. Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond). 1988; 74: 577–585.[Medline] [Order article via Infotrieve]
16. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med. 1978; 64: 193–198.[CrossRef][Medline] [Order article via Infotrieve]
17. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 1982; 21: 371–378.[Medline] [Order article via Infotrieve]
18. Dustan HP, Valdes G, Bravo EL, Tarazi RC. Excessive sodium retention as a characteristic of salt-sensitive hypertension. Am J Med Sci. 1986; 292: 67–74.[Medline] [Order article via Infotrieve]
19. Schmidlin O, Forman A, Tanaka M, Sebastian A, Morris RC Jr. NaCl-induced renal vasoconstriction in salt-sensitive African-Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension. 1999; 33: 633–639.
20. Schmidlin O, Forman A, Sebastian A, Morris RC Jr. What initiates the pressor effect of salt in salt-sensitive humans? Observations in normotensive blacks. Hypertension. 2007; 49: 1032–1039.
21. Qi N, Rapp JP, Brand PH, Metting PJ, Britton SL. Body fluid expansion is not essential for salt-induced hypertension in SS/Jr rats. Am J Physiol. 1999; 277: R1392–R1400.[Medline] [Order article via Infotrieve]
22. Friedman SM, McIndoe RA, Tanaka M. The relation of blood sodium concentration to blood pressure in the rat. J Hypertens. 1990; 8: 61–66.[CrossRef][Medline] [Order article via Infotrieve]
23. Huang BS, Van Vliet BN, Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol. 2004; 287: H1160–H1166.
24. Kawano Y, Yoshida K, Kawamura M, Yoshimi H, Ashida T, Abe H, Imanishi M, Kimura G, Kojima S, Kuramochi M, Omae T. Sodium and noradrenaline in cerebrospinal fluid and blood in salt- sensitive and non-salt-sensitive essential hypertension. Clin Exp Pharmacol Physiol. 1992; 19: 235–241.[Medline] [Order article via Infotrieve]
25. Bunag RD, Miyajima E. Sympathetic hyperactivity elevates blood pressure during acute cerebroventricular infusions of hypertonic salt in rats. J Cardiovasc Pharmacol. 1984; 6: 844–851.[Medline] [Order article via Infotrieve]
26. Nakamura K, Cowley AW Jr. Sequential changes of cerebrospinal fluid sodium during the development of hypertension in Dahl rats. Hypertension. 1989; 13: 243–249.
27. Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol. 2006; 21: 295–304.[Medline] [Order article via Infotrieve]
28. Campese VM, Parise M, Karubian F, Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension. 1991; 18: 805–812.
29. Sanai T, Kimura G. Renal function reserve and sodium sensitivity in essential hypertension. J Lab Clin Med. 1996; 128: 89–97.[CrossRef][Medline] [Order article via Infotrieve]
30. Hollenberg NK, Williams GH. Abnormal renal function, sodium-volume homeostasis and renin-system behavior in normal-renin hypertension: the evolution of the non-modulator concept. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995: 1837–1856.
31. van Paasen P, De Zeeuw D, Navis G, De Jong PE. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? Hypertension. 1996; 27: 202–208.
32. Wyss JM, Liumsiricharoen M, Sripairojthikoon W, Brown D, Gist R, Oparil S. Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat. Hypertension. 1987; 9: III/171–III/175.[Medline] [Order article via Infotrieve]
33. Tanaka M, Schmidlin O, Yi S-L, Bollen AW, Morris RC Jr. Genetically determined chloride-sensitive hypertension and stroke. Proc Natl Acad Sci U S A. 1997; 94: 14748–14752.
34. Schmidlin O, Tanaka M, Bollen AW, Yi SL, Morris RC Jr. Chloride-dominant salt sensitivity in the stroke-prone spontaneously hypertensive rat. Hypertension. 2005; 45: 867–873.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |